Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status

INTRODUCTION: Cerebrospinal fluid (CSF) biomarkers can identify individuals with Alzheimer disease (AD) pathology (e.g., amyloid plaques, neurofibrillary tangles), but defined analyte cut-points using high-throughput automated assays are necessary for general clinical use. METHODS: CSF Aβ42, t-tau,...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Alzheimers Dement
Autori principali: Kaplow, June, Vandijck, Manu, Gray, Julia, Kanekiyo, Michio, Huyck, Els, Traynham, CJ, Esquivel, Rianne, Fagan, Anne M., Luthman, Johan
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7061432/
https://ncbi.nlm.nih.gov/pubmed/31914216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alz.12000
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi